Workflow
Chemours(CC)
icon
Search documents
Chemours (CC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research· 2024-05-01 00:06
Chemours (CC) reported $1.35 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 12.1%. EPS of $0.32 for the same period compares to $0.98 a year ago.The reported revenue represents a surprise of -0.76% over the Zacks Consensus Estimate of $1.36 billion. With the consensus EPS estimate being $0.25, the EPS surprise was +28.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...
Chemours (CC) Q1 Earnings Surpass Estimates
Zacks Investment Research· 2024-04-30 22:56
Chemours (CC) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 28%. A quarter ago, it was expected that this chemical company would post earnings of $0.29 per share when it actually produced earnings of $0.31, delivering a surprise of 6.90%.Over the last four quarters, the company has ...
Chemours(CC) - 2024 Q1 - Quarterly Results
2024-04-30 20:32
EXHIBIT 99.1 Wilmington, Del., April 30, 2024 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies ("TT"), Thermal & Specialized Solutions ("TSS"), and Advanced Performance Materials ("APM"), today announced its financial results for the first quarter 2024. • Net Sales of $1.4 billion, down 12% year-over-year • Adjusted EBITDA 1,2 was $193 million, compared to $304 million in the corresponding prior-year quarter • ...
Chemours(CC) - 2024 Q1 - Quarterly Report
2024-04-30 20:25
The scope of the Audit Committee Internal Review included, among other things, reviewing (i) the process for reviewing reports made to the Chemours Ethics Hotline; (ii) the Company's practice for managing working capital, including the related impact on metrics within the Company's incentive plans; and (iii) certain non-GAAP metrics included in filings made with the Securities and Exchange Commission or otherwise publicly released, and related disclosures. and reclassifi ed Cash flows from operating activit ...
Chemours (CC) Up 2.9% Since Last Earnings Report: Can It Continue?
Zacks Investment Research· 2024-04-26 16:31
It has been about a month since the last earnings report for Chemours (CC) . Shares have added about 2.9% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Chemours due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Chemours’ Q4 Earnings Beat, Revenue Miss EstimatesChemo ...
CC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Case
Newsfilter· 2024-04-23 02:05
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of The Chemours Company (NYSE:CC) common stock have until Monday, May 20, 2024 to seek appointment as lead plaintiff of the Chemours class action lawsuit. Captioned Taylor v. The Chemours Company, No. 1:24-cv-00361 (D. Del.), the Chemours class action lawsuit charges Chemours and certain of Chemours' top current and former executives with violations of the Securities Exchange Act of 1934. If ...
Chemours (CC) Recently Broke Out Above the 20-Day Moving Average
Zacks Investment Research· 2024-04-02 14:36
From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 20-day moving average, and this suggests a short-term bullish trend.A well-liked tool among traders, the 20-day simple moving average offers a look back at a stock's price over a 20-day period. This is very beneficial to short-term traders, as it smooths out short-term price trends and gives more trend reversal signals than longer-term moving averages.Like othe ...
Chemours (CC) Just Reclaimed the 50-Day Moving Average
Zacks Investment Research· 2024-04-02 14:31
From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 50-day moving average, and this suggests a short-term bullish trend.One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down tren ...
Chemours(CC) - 2023 Q4 - Earnings Call Transcript
2024-03-29 02:25
Financial Data and Key Metrics Changes - Fourth quarter net loss on a GAAP basis was $18 million or $0.12 per diluted share, while adjusted net income was $46 million compared to $480,000 in the prior year quarter [10][11] - Consolidated fourth quarter 2023 net sales increased 2% year-over-year to $1.4 billion, with adjusted EBITDA rising to $176 million from $120 million in the prior year quarter [20][11] - For the full year 2023, consolidated net sales were $6 billion, down 11% from the prior year, with a GAAP net loss of $238 million or $1.60 per diluted share [23][24] Business Segment Data and Key Metrics Changes - Titanium Technologies (TT) segment sales increased 7% year-over-year to $651 million, driven by a 12% increase in volume, while prices declined 6% [24][51] - Thermal and Specialty Solutions (TSS) segment sales increased 17% to $374 million, driven by demand for Opteon refrigerants, with adjusted EBITDA reaching $124 million [20][53] - Advanced Performance Materials (APM) segment sales declined 15% to $325 million, primarily due to an 18% decrease in volume [25][51] Market Data and Key Metrics Changes - The TT segment saw improved demand outside of North America, while the North American market experienced a decline [24][51] - The TSS segment benefited from regulatory changes favoring low global warming potential refrigerants, with significant growth expected in this area [18][59] - APM faced challenges due to softness in economically sensitive markets, particularly affecting the Advanced Materials portfolio [25][30] Company Strategy and Development Direction - The company is focused on cost reduction through the TT transformation plan, aiming to enhance productivity and efficiency [7][47] - Growth projects in APM are targeting high-potential applications such as hydrogen production and electric vehicles [8][18] - The company is committed to being the lowest-cost producer while investing in attractive growth opportunities [77][79] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges but emphasized opportunities for growth and profitability, with a focus on operational integrity [4][32] - The company expects a sequential decline in TT and APM net sales for the first quarter of 2024, driven by weaker demand and production challenges [29][30] - Management expressed confidence in the long-term growth prospects of TSS despite near-term headwinds [59][61] Other Important Information - As of December 31, 2023, the company had $1.2 billion in unrestricted cash and $4.1 billion in gross debt, resulting in a net leverage ratio of approximately 2.8x [26][27] - The company identified four material weaknesses in internal controls but stated these did not result in material misstatements [28] - The company returned $218 million to shareholders in 2023 through dividends and share repurchases [27] Q&A Session All Questions and Answers Question: Can you speak to the measures that you're going to be taking to strengthen the bench? - Management stated that there is no attrition problem and emphasized the stability and experience within the organization, while also seeking to bring stability to the executive team [62] Question: How should we think about the TiO2 business as it pushes higher throughout 2024? - Management indicated that strategic decisions were made to prepare for market recovery, with expectations of a 15% increase in volume going into Q2 [63] Question: How do you see the industry being affected by a new chloride-based TiO2 competitor? - Management highlighted the importance of being the lowest-cost producer and competing effectively in all market scenarios [83] Question: Can you provide color around the $125 million cost savings? - Management indicated that the cost savings would be ratable throughout the year, focusing on mining and process technology improvements [80][102] Question: What are your expectations for TiO2 volumes for the first quarter? - Management confirmed expectations of a 10% sequential decline in TiO2 volumes for Q1, with a projected 15% increase in Q2 [101][105]
Chemours(CC) - 2023 Q4 - Annual Results
2024-03-27 22:09
EXHIBIT 99.1 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------|------------------|--------------------------------------------------------------------------------|--------------------------|---------------------------------------------|----------------|----------------------------------------------------------------------|-------|----------------------------- ...